Lavelle Erin M. 4
4 · Neoleukin Therapeutics, Inc. · Filed Jun 2, 2020
Insider Transaction Report
Form 4
Lavelle Erin M.
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-01+50,000→ 50,000 totalExercise: $13.58Exp: 2030-06-01→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/3 of the total shares on each of June 1, 2021, June 1, 2022 and June 1, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date.